Bifogade filer
Kurs & Likviditet
+1,36%
|
89,8 MSEK
Kursutveckling och likviditet under dagen för detta pressmeddelande
Kalender
2025-01-30 | Bokslutskommuniké 2024 |
2024-10-24 | Kvartalsrapport 2024-Q3 |
2024-07-17 | Kvartalsrapport 2024-Q2 |
2024-04-26 | Ordinarie utdelning VITR 1.00 SEK |
2024-04-25 | Årsstämma 2024 |
2024-04-18 | Kvartalsrapport 2024-Q1 |
2024-02-02 | Bokslutskommuniké 2023 |
2023-10-27 | Kvartalsrapport 2023-Q3 |
2023-07-14 | Kvartalsrapport 2023-Q2 |
2023-04-28 | Ordinarie utdelning VITR 0.85 SEK |
2023-04-27 | Årsstämma 2023 |
2023-04-21 | Kvartalsrapport 2023-Q1 |
2023-02-02 | Bokslutskommuniké 2022 |
2022-10-27 | Kvartalsrapport 2022-Q3 |
2022-07-15 | Kvartalsrapport 2022-Q2 |
2022-04-28 | Ordinarie utdelning VITR 0.80 SEK |
2022-04-27 | Årsstämma 2022 |
2022-04-22 | Kvartalsrapport 2022-Q1 |
2022-02-16 | Bokslutskommuniké 2021 |
2021-10-29 | Kvartalsrapport 2021-Q3 |
2021-10-20 | Extra Bolagsstämma 2021 |
2021-07-15 | Kvartalsrapport 2021-Q2 |
2021-04-29 | Ordinarie utdelning VITR 0.80 SEK |
2021-04-28 | Årsstämma 2021 |
2021-04-22 | Kvartalsrapport 2021-Q1 |
2021-02-10 | Bokslutskommuniké 2020 |
2020-11-06 | Kvartalsrapport 2020-Q3 |
2020-07-13 | Kvartalsrapport 2020-Q2 |
2020-06-16 | Ordinarie utdelning VITR 0.00 SEK |
2020-06-15 | Årsstämma 2020 |
2020-04-23 | Kvartalsrapport 2020-Q1 |
2020-02-06 | Bokslutskommuniké 2019 |
2019-11-06 | Kvartalsrapport 2019-Q3 |
2019-07-12 | Kvartalsrapport 2019-Q2 |
2019-05-03 | Ordinarie utdelning VITR 0.85 SEK |
2019-05-02 | Årsstämma 2019 |
2019-04-23 | Kvartalsrapport 2019-Q1 |
2019-02-08 | Bokslutskommuniké 2018 |
2018-11-06 | Kvartalsrapport 2018-Q3 |
2018-07-13 | Kvartalsrapport 2018-Q2 |
2018-05-17 | Split VITR 1:5 |
2018-04-27 | Ordinarie utdelning VITR 3.70 SEK |
2018-04-26 | Årsstämma 2018 |
2018-04-24 | Kvartalsrapport 2018-Q1 |
2018-02-08 | Bokslutskommuniké 2017 |
2017-11-02 | Kvartalsrapport 2017-Q3 |
2017-07-14 | Kvartalsrapport 2017-Q2 |
2017-04-28 | Ordinarie utdelning VITR 2.60 SEK |
2017-04-27 | Årsstämma 2017 |
2017-04-25 | Kvartalsrapport 2017-Q1 |
2017-02-09 | Bokslutskommuniké 2016 |
2016-11-03 | Kvartalsrapport 2016-Q3 |
2016-09-20 | Kapitalmarknadsdag 2016 |
2016-07-15 | Kvartalsrapport 2016-Q2 |
2016-04-29 | Ordinarie utdelning VITR 2.40 SEK |
2016-04-28 | Årsstämma 2016 |
2016-04-26 | Kvartalsrapport 2016-Q1 |
2016-02-05 | Bokslutskommuniké 2015 |
2015-11-05 | Kvartalsrapport 2015-Q3 |
2015-07-14 | Kvartalsrapport 2015-Q2 |
2015-05-06 | Ordinarie utdelning VITR 1.50 SEK |
2015-05-05 | Årsstämma 2015 |
2015-04-28 | Kvartalsrapport 2015-Q1 |
2015-02-06 | Bokslutskommuniké 2014 |
2014-11-06 | Kvartalsrapport 2014-Q3 |
2014-11-06 | Analytiker möte 2014 |
2014-11-06 | Kapitalmarknadsdag 2014 |
2014-07-11 | Kvartalsrapport 2014-Q2 |
2014-05-06 | Ordinarie utdelning VITR 1.00 SEK |
2014-05-05 | Årsstämma 2014 |
2014-04-23 | Kvartalsrapport 2014-Q1 |
2014-02-06 | Bokslutskommuniké 2013 |
2013-11-11 | Kapitalmarknadsdag 2013 |
2013-11-07 | Kvartalsrapport 2013-Q3 |
2013-11-07 | Analytiker möte 2013 |
2013-07-12 | Kvartalsrapport 2013-Q2 |
2013-04-30 | Ordinarie utdelning VITR 0.60 SEK |
2013-04-29 | Årsstämma 2013 |
2013-04-19 | Kvartalsrapport 2013-Q1 |
2013-03-13 | 15-7 2013 |
2013-02-07 | Bokslutskommuniké 2012 |
2012-11-01 | Analytiker möte 2012 |
2012-11-01 | Kvartalsrapport 2012-Q3 |
2012-09-24 | Extra Bolagsstämma 2012 |
2012-07-13 | Kvartalsrapport 2012-Q2 |
2012-04-20 | Ordinarie utdelning VITR 0.60 SEK |
2012-04-19 | Kvartalsrapport 2012-Q1 |
2012-04-19 | Årsstämma 2012 |
2012-02-07 | Bokslutskommuniké 2011 |
2011-10-27 | Kvartalsrapport 2011-Q3 |
2011-07-14 | Kvartalsrapport 2011-Q2 |
2011-04-28 | Ordinarie utdelning VITR 0.60 SEK |
2011-04-27 | Kvartalsrapport 2011-Q1 |
2011-04-27 | Årsstämma 2011 |
2011-02-09 | Bokslutskommuniké 2010 |
2010-11-02 | Kvartalsrapport 2010-Q3 |
2010-07-15 | Kvartalsrapport 2010-Q2 |
2010-04-27 | Kvartalsrapport 2010-Q1 |
2010-04-27 | Ordinarie utdelning VITR 0.50 SEK |
2010-04-26 | Årsstämma 2010 |
2010-02-05 | Bokslutskommuniké 2009 |
2009-11-03 | Kvartalsrapport 2009-Q3 |
2009-07-15 | Kvartalsrapport 2009-Q2 |
2009-04-28 | Ordinarie utdelning VITR 0.40 SEK |
2009-04-27 | Kvartalsrapport 2009-Q1 |
2009-04-27 | Årsstämma 1 |
Beskrivning
Land | Sverige |
---|---|
Lista | Large Cap Stockholm |
Sektor | Hälsovård |
Industri | Medicinteknik |
2021-10-29 08:00:00
Third quarter:
- Sales amounted to SEK 406 (320) million, corresponding to an increase of 27 percent in SEK. Sales increased by 30 percent in local currency.
- Operating income before depreciation and amortisation (EBITDA) amounted to SEK 162 (134) million, corresponding to a margin of 40 (42) percent. Currency effects positively impacted EBITDA by SEK 1 million. Operating income included non-recurring acquisition-related costs of SEK 8 million. Adjusted EBITDA therefore amounted to SEK 170 million, corresponding to a margin of 42 percent.
- Net income amounted to SEK 105 (89) million, which gave earnings per share of SEK 0.89 (0.81).
- Vitrolife entered into an agreement to acquire 100% of the shares in Igenomix for a purchase sum of EUR 1.25 billion (approximately SEK 12.7 billion). During the quarter a directed share issue of SEK 3.6 billion was carried out as part-financing of the acquisition.
- Sales amounted to SEK 1 167 (863) million, corresponding to an increase of 35 percent in SEK. Sales increased by 41 percent in local currency.
- EBITDA amounted to SEK 460 (290) million, corresponding to a margin of 39 (34) percent. Currency effects negatively impacted EBITDA by SEK 24 million. Operating income included non-recurring acquisition-related costs of SEK 22 million and non-recurring transport-related costs of SEK 3 million. Adjusted EBITDA therefore amounted to SEK 485 million, corresponding to a margin of 42 percent.
- Net income amounted to SEK 310 (180) million, which gave earnings per share of SEK 2.77 (1.65).
- An Extraordinary General Meeting resolved to approve the Board's proposal regarding a non-cash issue of shares for SEK 6.4 billion as part-financing of the acquisition of Igenomix.
- Patrik Tolf has been appointed new CFO of Vitrolife AB (publ) effective 1 January 2022.
Gothenburg, October 29, 2021
VITROLIFE AB (publ)
Thomas Axelsson, CEO
Queries should be addressed to:
Thomas Axelsson, CEO, tel 46 31 721 80 01
Mikael Engblom, CFO, tel 46 31 721 80 14
This information is information that Vitrolife AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 8.00 am CET on October 29, 2021.
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.